Rockefeller Capital Management L.P. - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$2
-99.9%
2,0000.0%0.00%
Q3 2022$2,000
-33.3%
2,0000.0%0.00%
Q2 2022$3,000
-25.0%
2,0000.0%0.00%
Q1 2022$4,000
-42.9%
2,0000.0%0.00%
Q4 2021$7,000
-30.0%
2,0000.0%0.00%
Q3 2021$10,000
+25.0%
2,0000.0%0.00%
Q2 2021$8,000
-20.0%
2,0000.0%0.00%
Q1 2021$10,0000.0%2,0000.0%0.00%
Q4 2020$10,000
-44.4%
2,000
-14.5%
0.00%
Q3 2020$18,000
-10.0%
2,339
+17.0%
0.00%
Q2 2020$20,000
+300.0%
2,0000.0%0.00%
Q1 2020$5,000
+150.0%
2,0000.0%0.00%
Q4 2019$2,0002,0000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 38,974,185$166,030,0001.81%
Endurant Capital Management LP 1,539,435$6,558,0001.80%
NEA Management Company, LLC 17,082,611$72,772,0000.95%
PFM Health Sciences, LP 3,627,900$15,455,0000.48%
GSA CAPITAL PARTNERS LLP 513,388$2,187,0000.25%
Baker Brothers Advisors 9,830,877$41,880,0000.18%
Avoro Capital Advisors LLC 2,024,400$8,624,0000.15%
Vigilare Wealth Management 54,250$231,0000.14%
AlphaCentric Advisors LLC 120,000$511,0000.14%
Rock Springs Capital Management LP 1,545,000$6,582,0000.13%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders